Anti-Oxidative, Anti-Inflammatory and Anti-Apoptotic Effects of Flavonols: Targeting Nrf2, NF-κB and p53 Pathways in Neurodegeneration
Open Access
- 15 October 2021
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 10 (10) , 1628
Abstract
Neurodegenerative diseases are one of the leading causes of disability and death worldwide. Intracellular transduction pathways that end in the activation of specific transcription factors are highly implicated in the onset and progression of pathological changes related to neurodegeneration, of which those related to oxidative stress (OS) and neuroinflammation are particularly important. Here, we provide a brief overview of the key concepts related to OS- and neuroinflammation-mediated neuropathological changes in neurodegeneration, together with the role of transcription factors nuclear factor erythroid 2–related factor 2 (Nrf2) and nuclear factor-κB (NF-κB). This review is focused on the transcription factor p53 that coordinates the cellular response to diverse genotoxic stimuli, determining neuronal death or survival. As current pharmacological options in the treatment of neurodegenerative disease are only symptomatic, many research efforts are aimed at uncovering efficient disease-modifying agents. Natural polyphenolic compounds demonstrate powerful anti-oxidative, anti-inflammatory and anti-apoptotic effects, partially acting as modulators of signaling pathways. Herein, we review the current understanding of the therapeutic potential and limitations of flavonols in neuroprotection, with emphasis on their anti-oxidative, anti-inflammatory and anti-apoptotic effects along the Nrf2, NF-κB and p53 pathways. A better understanding of cellular and molecular mechanisms of their action may pave the way toward new treatments.Keywords
Funding Information
- Hrvatska Zaklada za Znanost (IP-2016-06-8415)
This publication has 321 references indexed in Scilit:
- p53 Opens the Mitochondrial Permeability Transition Pore to Trigger NecrosisCell, 2012
- Morin attenuates tau hyperphosphorylation by inhibiting GSK3βNeurobiology of Disease, 2011
- Transcription factor p53 influences microglial activation phenotypeGlia, 2011
- The non‐apoptotic role of p53 in neuronal biology: enlightening the dark side of the moonEMBO Reports, 2009
- Glutathionylation of the Pro-apoptotic Protein p53 in Alzheimer’s Disease Brain: Implications for AD PathogenesisNeurochemical Research, 2009
- The neuroprotective potential of flavonoids: a multiplicity of effectsGenes & Nutrition, 2008
- ROS and p53: A versatile partnershipFree Radical Biology and Medicine, 2008
- p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cellsNeuroscience Letters, 2007
- Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memoryProceedings of the National Academy of Sciences, 2006
- The tumor suppressor protein p53 is required for neurite outgrowth and axon regenerationThe EMBO Journal, 2006